UPLOAD Filing
Connect Biopharma Holdings Ltd
Date: June 12, 2025 · CIK: 0001835268 · Accession: 0000000000-25-006235
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287918
Letter
Re: Connect Biopharma Holdings Limited Registration Statement on Form F-3 Filed June 10, 2025 File No. 333-287918 Dear Jeff Cohn Esq.:
June 12, 2025
Jeff Cohn, Esq. General Counsel and Corporate Secretary Connect Biopharma Holdings Limited 3580 Carmel Mountain Road, Suite 200 San Diego, CA 92130
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Michael E. Sullivan, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> June 12, 2025 Jeff Cohn, Esq. General Counsel and Corporate Secretary Connect Biopharma Holdings Limited 3580 Carmel Mountain Road, Suite 200 San Diego, CA 92130 Re: Connect Biopharma Holdings Limited Registration Statement on Form F-3 Filed June 10, 2025 File No. 333-287918 Dear Jeff Cohn Esq.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Michael E. Sullivan, Esq. </TEXT> </DOCUMENT>